Top Clinical Trials companies in Belgium by Total Liabilities

This ranking features the top 5 Clinical Trials companies in Belgium ranked by Total Liabilities, totaling a Total Liabilities of USD 8.30 B, for July 04, 2025.

#	Name	Market Capitalization Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue Revenue Year-on-Year (YoY) growth Operating Income EBIT EBITDA Free Cash Flow Dividend Yield Free Cash Flow Yield Total Assets Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

Frequently Asked Questions

Which Clinical Trials company in Belgium has the highest Total Liabilities ?

The Clinical Trials company in Belgium with the highest Total Liabilities is UCB SA (Brussels Stock Exchange: UCB.BR) at USD 7.58 B.

Which Clinical Trials company in Belgium has the lowest Total Liabilities ?

The Clinical Trials company in Belgium with the lowest Total Liabilities is Hyloris Pharmaceuticals SA (Brussels Stock Exchange: HYL.BR) at USD 9.52 M.

What are the top 10 Clinical Trials companies in Belgium by Total Liabilities ?

The top 10 Clinical Trials companies in Belgium by Total Liabilities are UCB SA, Ion Beam Applications SA, MDxHealth SA, Nyxoah S.A. and Hyloris Pharmaceuticals SA.

What are the bottom 10 Clinical Trials companies in Belgium by Total Liabilities ?

The bottom 10 Clinical Trials companies in Belgium by Total Liabilities are Hyloris Pharmaceuticals SA, Nyxoah S.A., MDxHealth SA, Ion Beam Applications SA and UCB SA.